ReviewBehavioural neurology2025
Apathy in Neuropsychiatric Disorders: Clinical Characteristics, Neurobiological Mechanisms, and Therapeutic Strategies.
Review in Behavioural neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Exploring the potential of cognitive intra-individual variability in HIV care and research in adults with HIV: a concept analysis.Applied neuropsychology. Adult · 2026Review
- Bilateral DLPFC transcranial direct current stimulation for mood and motor symptoms in Parkinson's disease: a preliminary study.Acta neuropsychiatrica · 2026Article
- Multimodal Neuroimaging Mechanisms of Apathy in Alzheimer's Disease: A Narrative Review of Structural, Functional, and Molecular Evidence.International journal of general medicine · 2026Review
- Neuropsychiatric symptoms in mild cognitive impairment and early Alzheimer's disease: Clinical pattern and diagnostic implications.AIMS neuroscience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Apathy is a prevalent yet frequently underrecognized neuropsychiatric syndrome characterized by diminished motivation and reduced goal-directed behavior across multiple domains. It is strongly associated with poorer functional outcomes, increased caregiver burden, and decreased quality of life in various neuropsychiatric conditions. Despite its clinical importance, apathy remains underdiagnosed and undertreated, partly due to overlapping features with depression and cognitive impairment. This narrative review synthesizes current knowledge on conceptualization, neurobiological mechanisms, diagnostic criteria, and management strategies for apathy, adopting a transdiagnostic perspective across disorders such as Alzheimer's disease, Parkinson's disease, frontotemporal dementia, multiple sclerosis, and major psychiatric conditions. This review distinguishes itself by integrating subtype-based approaches, biomarker insights, and emerging digital tools, providing a framework for more precise characterization and personalized intervention. This review is based on a nonsystematic literature search conducted in PubMed, Scopus, and Google Scholar for articles published between 2011 and 2025. Improved characterization and management of apathy are essential for optimizing patient outcomes, reducing caregiver burden, and guiding future research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.